PAXIL CR Bioequivalence Study

Clinical trial NCT00749359 · COMPLETED

Trial details

NCT number: NCT00749359
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2008-07-07
Primary completion: 2008-09-16
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.